Evidence map›Paper›PMID 32033143›Full record

ArticleInternational journal of molecular sciences2020

Integrated Genome-Wide Analysis of an Isogenic Pair of

Weihua Huang, Joelle El Hamouche, Guiqing Wang, Melissa Smith, Changhong Yin, Abhay Dhand, Nevenka Dimitrova, John T Fallon

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. L2 β-lactamase contributes to ceftolozane-tazobactam resistance inAntimicrobial agents and chemotherapy · 2026
    Article
  2. A novel mechanism of ceftolozane-tazobactam resistance inbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Comparative genomics and DNA methylation analysis ofFrontiers in cellular and infection microbiology · 2023
    Article
  8. Article
  9. Prediction of Potential Drug Targets and Vaccine Candidates Against Antibiotic-ResistantInternational journal of peptide research and therapeutics · 2022
    Article
  10. UnderstandingCells · 2020
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Weihua HuangDepartment of Pathology, New York Medical College, Valhalla, NY 10595, USA.
Joelle El HamoucheDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11790, USA.
Guiqing WangDepartment of Pathology, New York Medical College, Valhalla, NY 10595, USA.
Melissa SmithDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Changhong YinDepartment of Pathology, New York Medical College, Valhalla, NY 10595, USA.
Abhay DhandDepartment of Medicine, New York Medical College, Valhalla, NY 10595, USA.
Nevenka DimitrovaPhilips Research North America, Cambridge, MA 02141, USA.
John T FallonDepartment of Pathology, New York Medical College, Valhalla, NY 10595, USA.ORCID 0000-0002-7677-4868
New York Medical College · USWestchester Medical Center · USIcahn School of Medicine at Mount Sinai · USPhilips (United States) · USStony Brook University · US

Funding

Philips Research North America N/A
6 · The paper itself

Abstract

Multidrug-resistant (MDR)

Indexed as

AgedAnti-Bacterial AgentsAzabicyclo CompoundsCeftazidimeCephalosporinsDrug CombinationsDrug Resistance, BacterialFemaleGenome-Wide Association StudyHumansMicrobial Sensitivity TestsPiperacillinPseudomonas aeruginosaPseudomonas InfectionsTazobactamAnti-Bacterial Agentsavibactamavibactam, ceftazidime drug combinationAzabicyclo CompoundsCeftazidimeceftolozaneceftolozane, tazobactam drug combinationCephalosporinsDrug CombinationsPiperacillinTazobactamantimicrobial resistanceceftazidime/avibactam (CZA)ceftolozane/tazobactam (C/T)epigenetic profilingpiperacillin/tazobactam (P/T)Pseudomonas aeruginosaRNA sequencing (RNAseq)whole-genome sequencing (WGS)

Identifiers

PMID32033143
PMCPMC7037351
OpenAlexW3005025720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.